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INTRODuCTION: CD95 AND CD95 SIGNALING
cD95 (also called APO-1; Fas; fas antigen; tumor necrosis 
factor receptor superfamily member 6, tnFrSF6 or apopto-
sis antigen 1, APt1) is a member of the death receptor (Dr) 
family, a subfamily of the tumor necrosis factor receptor su-
perfamily (1). All members of the Dr family are character-
ized by a cytoplasmic region termed the Death Domain (DD) 
(2;3). DD are 80-100 amino acid long motifs involved in the 
transduction of the apoptotic signal. the DD belongs to the 
so-called ‘death domain-fold superfamily’. this superfamily 
comprises the death domain (DD), the death effector domain 
(DeD), and the caspase recruitment domain (cArD). each 
of these motifs interacts with other proteins through homo-
typic interactions. All members of the DD-fold superfamily 
are characterized by similar structures that comprise six or 
seven antiparallel amphipatic α-helices. 
crosslinking of cD95 with its natural ligand, cD95L 
(cD178) (4), or with agonistic antibodies, such as anti-APO-1 
(5), induces apoptosis in sensitive cells. the binding of cD95L 
or agonistic antibodies to cD95 leads to the formation of 
the receptor complex at the cellular membrane, which was 
named death-inducing signaling complex (DISc) (6). the 
DISc consists of oligomerized receptors, the DD-containing 
adaptor molecule FADD/MOrt1 (Fas-Associated Death 
Domain), procaspase-8 (FLIce, MAcHα, Mch5), procas-
pase-10, and the cellular FLIce-inhibitory proteins (c-FLIP) 
(Fig. 1) (7-9). the interactions between the molecules at the 
DISc are based on homotypic contacts. the DD of the recep-
tor interacts with the DD of FADD, while the DeD of FADD 
interacts with the n-terminal tandem DeDs of procaspas-
es-8, -10 and c-FLIP. As a result of DISc formation procas-
pase-8 is activated at the DISc resulting in the formation of 
the active caspase-8. caspase-8 cleaves and thereby acti-
vates downstream effector caspases-3, -6, and -7. this is fol-
lowed by the cleavage of caspase substrates, which comprise 
a number of cellular proteins playing a central role for the 
normal functioning of the cell leading to demolition of the 
cell.  
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DeD proteins at the DISc play a central role in the regu-
lation of Dr-induced apoptosis. recruitment of procaspase-8 
to the DISc, followed by its activation at the DISc and for-
mation of active caspase-8 heterotetramers, triggers the 
apoptotic pathway. recruitment of c-FLIP proteins to the 
DISc has the opposite effect: c-FLIP proteins block procas-
pase-8 activation at the DISc and thereby apoptosis induc-
tion. therefore, life/death decisions at the DISc are defined 
by the balance of two DeD proteins: procaspase-8 and c-
FLIP. In this review we describe in detail the DeD-proteins 
procaspase-8 and c-FLIP and the mechanism of their pro- 
and anti-apoptotic action.
PROAPOPTOTIC DED PROTEINS OF THE DISC: 
PROCASPASE-8 AS A MEMBER OF THE CASPASE FAMILy
Procaspase-8 (FLIce, MAcHα, Mch5) belongs to the family 
of caspases (7;10). caspases, a family of cysteinyl aspartate 
specific proteases, are synthesized as zymogens with a pro-
domain of variable length followed by a large subunit (p20) 
and a small subunit (p10). caspases are activated through 
proteolysis at specific aspartate (D) residues that are located 
between the prodomain, the p20, and p10 subunits (Fig. 2) 
(11). this results in the generation of mature active caspases 
that consist of heterotetramers p202-p102. Subsequently, ac-
tive caspases specifically process various substrates that are 
involved in apoptosis and inflammation. Depending on their 
function and the structure of the prodomain, caspases are 
divided into initiator caspases and effector caspases and are 
typically divided into three major groups (Fig. 3) (11). the 
caspases with large prodomains are referred to as inflam-
matory caspases (group I) and initiator of apoptosis caspases 
(group II), while caspases with a short prodomain of 20-30 
amino acids are named effector caspases (group III). 
All caspases are produced in cells as catalytically inac-
tive zymogens and must undergo proteolytic processing and 
activation during apoptosis (12). the effector caspases are 
activated by initiator caspases. In turn, initiator caspase ac-
tivation takes place in large protein complexes bringing to-
gether several caspase zymogens. All initiator caspases are 
characterized by the presence of a member of the ‘death do-
main-fold superfamily’ (DeD or cArD), which enables their 
recruitment into their initiation complexes. Procaspases-8 
and -10 possess two tandem DeDs in their prodomain (Fig. 
3). the cArD is found in procaspases-1, -2, -4, -5, -9, -11, 
and –12 (Fig. 3). DeDs and cArDs are responsible for the 
recruitment of initiator caspases into death- or inflamma-
tion-inducing signaling complexes resulting in proteolytic 
autoactivation of caspases that subsequently initiates in-
flammation or apoptosis. 
Procaspase-8 is activated at the DISc (13). two isoforms 
of procaspase-8 (procaspase-8a and procaspase-8b) were re-
ported to be bound to the DISc (14). Both isoforms possess 
two tandem DeD domains, as well as the catalytic subunits 
p18 and p10 (Fig. 4). Procaspase-8a contains an additional 2 
kDa (15 aa) fragment, which results from the translation of 
exon 9. this small fragment is located between the second 
DeD and the large catalytic subunit resulting in the differ-
ent length of procaspase-8a (p55) and, consequently, procas-
pase-8b (p53).
the activation of procaspase-8 is believed to follow an ‘in-
duced proximity’ model in which high local concentrations 
and favourable mutual orientation of procaspase-8 mol-
ecules at the DISc lead to their autoproteolytic activation 
(15). there is strong evidence from several in vitro studies 
that autoproteolytic activation of procaspase-8 occurs after 
Figure 1. The CD95 death‑inducing signaling complex (DISC). The DISC 
consists of CD95, (depicted in yellow), FAS‑associated death domain, 
FADD, (depicted in light blue), procaspase‑8/procaspase‑10, (de‑
picted in green), and cellular FLICE‑inhibitory proteins, c‑FLIP, (depicted 
in violet). DD are shown in red; DED are shown in light yellow. The 
interactions between the molecules at the DISC are based on homotypic 
contacts. The death domain (DD) of CD95 interacts with the DD of FADD 
while the death effector domain (DED) of FADD interacts with the N‑
terminal tandem DEDs of procaspase‑8, procaspase‑10 and c‑FLIP.
Figure 2. Scheme of procaspase activation. Cleavage of the procaspase 
at the specific Asp‑X bonds leads to the formation of the mature caspase 
that comprises the heterotetramer p202‑p102 and the release of the 
prodomain. The residues involved in the formation of the active center 
are shown.82 | ActA nAturAe |  № 1 2009
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oligomerization at the receptor complex (16). Furthermore, 
dimerization of two procaspase-8 molecules at the DISc has 
been shown to be necessary for procaspase-8 activation (17). 
Procaspase-8a/b at the DISc undergoes autocatalytic cleav-
age, for which a two-step mechanism has been described 
(Fig. 4) (14;18). the initial cleavage at Asp374 generates the 
two subunits p43/p41 and p12. In a second step, cleavage 
takes place at Asp216 and Asp384, producing the active enzyme 
subunits p18, p10 and the prodomains p26/p24. As a result 
of procaspase-8 processing, the caspase-8 heterotetramer 
(p18/p10)2 starts the apoptotic signaling cascade (19).
ANTI-APOPTOTIC DED-PROTEIN OF THE DISC: 
CELLuLAR FLICE-INHIBITORy PROTEINS (C-FLIP)
c-FLIP, also known as FLAMe-1/I-FLIce/cASPer/
cASH/MrIt/cLArP/usurpin, is a well-described inhibi-
tor of Dr-mediated apoptosis. the current view on c-FLIP 
proteins is shown in figure 5. Five c-FLIP proteins have been 
characterized so far: three c-FLIP isoforms and two cleav-
age products (9;20-24). the three c-FLIP isoforms comprise: 
Long (L), Short (S), and raji (r), e.g. c-FLIPL, c-FLIPS, and 
c-FLIPr, respectively (Fig. 5). All three isoforms possess two 
DeD domains and thereby bind to the DISc. In this way, the 
short FLIP isoforms, c-FLIPS, and c-FLIPr block procas-
pase-8 activation and apoptosis. the role of the long c-FLIP 
isoform, c-FLIPL, at the DISc is controversial. It has been 
shown that depending upon its concentration at the DISc it 
can act either as an anti-apoptotic molecule, functioning in a 
way analogous to c-FLIPS, or as a pro-apoptotic molecule, fa-
cilitating the activation of procaspase-8 at the DISc (25;26). 
this pro-apoptotic role is in agreement with the phenotype 
of c-FLIP-deficient mice, which are characterized by heart 
failure and death at embryonic day 11 (27).
In addition, two cleavage products of c-FLIP have been 
reported until now: p43-FLIP and p22-FLIP (9;24). P43-
FLIP was shown to be generated from c-FLIPL at the cD95 
DISc as a result of procaspase-8 cleavage at D376. P22-FLIP 
was shown to be the n-terminal cleavage product of c-FLIP 
resulting from procaspase-8 cleavage at D196. In contrast to 
p43-FLIP, p22-FLIP is formed in the cytosol independently 
of Dr-stimulation. In addition, p22-FLIP turned out to be a 
prominent inducer of nF-κB activity by binding to the IKK 
complex. 
Figure 3. The caspase family. 
Three major groups of caspases 
are presented. Group I: inflam‑
matory caspases. Group II: 
apoptosis initiator caspases. 
Group III: apoptosis effec‑
tor caspases. The caspase 
activation recruitment domain 
(CARD), the death effector 
domain (DED), the large (p20), 
and the small (p10) catalytic 
subunits are indicated.
Figure 4. Scheme of procaspase‑8 and the two‑step mechanism of pro‑
caspase‑8 activation. Procaspase‑8a/b (p55/p53) is shown in green; 
DEDs are presented in light yellow. The N‑terminal cleavage products: 
p43/p41 and prodomains p26/p24 as well as caspase‑active domains: 
p18 and p10 are indicated. Two cleavage steps with the resulting prod‑
ucts are presented.reVIeWS
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REGuLATION OF LIFE AND DEATH By DED PROTEINS
DeD proteins procaspase-8 and c-FLIP play a central role in 
the regulation of Dr-induced apoptosis and might also in-
duce the nF-κB pathway (6). regulation of Dr-induced ap-
optosis by procaspase-8 and c-FLIP occurs at the DISc.  (Fig. 
6. left side). Procaspase-8 is activated at the DISc inducing 
the apoptotic process, while this activation can be inhibited 
by all reported c-FLIP proteins. the only exception is the 
c-FLIPL isoform, which might induce procaspase-8 activa-
tion when expressed at low concentrations and block pro-
caspase-8 activation when expressed at high concentrations. 
therefore, procaspase-8 at the DISc has a pro-apoptotic role 
and c-FLIP proteins, except for the c-FLIPL isoform, possess 
an anti-apoptotic function.
Interestingly, in the cytosol, interactions between procas-
pase-8 and c-FLIP have been reported to induce the nF-κB 
pathway rather than apoptotic pathways. recently, a new 
nF-κB-activating pathway initiated by procaspase-8 has 
been described. It has been shown that, independently of 
Dr stimulation, non-apoptotic procaspase-8 activity gener-
ates the p22-FLIP cleavage product that leads to the induc-
tion of nF-κB (Fig. 6, right side). the role of procaspase-8 in 
this pathway is different from its pro-apoptotic activity at 
the DISc. Procaspase-8 does not undergo processing leading 
to apoptosis induction with active heterotetramer formation 
but rather utilizes its so-called proform activity processing 
c-FLIP to the p22-FLIP cleavage product. It is likely that 
procaspase-8 constitutively forms heterodimers with c-FLIP 
cleaving c-FLIP to p22-FLIP. thus, the ratio between pro-
caspase-8 and c-FLIP in cells would be the crucial factor de-
fining the amount of generated p22-FLIP and, correspond-
ingly, the potential to induce nF-κB. 
the balance between DeD-containing proteins may pro-
vide sensitive signaling check points that cells use for sign-
aling cross-talk and switching between apoptosis-resistant 
and sensitive phenotypes and, thus, between life and death. 
Furthermore, the balance between DeD-proteins also de-
pends on the subcellular localization. the regulation by c-
FLIP and procaspase-8 of life/death decisions at the DISc 
is different from the cytosolic events. At the DISc, c-FLIP 
mostly acts as a devoted procaspase-8 inhibitor, while in the 
cytosol it uses procaspase-8 activity to initiate cleavage to 
p22-FLIP and the subsequent nF-κB induction (Fig. 6). con-
sequently, procaspase-8 initiates apoptosis at the DISc and 
nF-κB in the cytosol. the crosstalk between the DeD pro-
teins in the cytosol and at the DISc will be a topic of future 
studies. 
Figure 5. The scheme of c‑FLIP proteins. c‑FLIP isoforms and c‑FLIP cleav‑
age products are shown. DED (Death effector domains) and caspase‑like 
domains (p20 an p12) are indicated. D376 and D196, leading to the 
generation of p43‑FLIP and p22‑FLIP, respectively, are presented in red.
Figure 6. DED proteins: procaspase‑8 and c‑FLIP at the DISC and in the 
cytosol. c‑FLIP proteins block procaspase‑8 activation at the DISC (left 
side). Procaspase‑8 and c‑FLIP form dimers in the cytosol leading to 
generation of p22‑FLIP. P22‑FLIP binds to IKK complex via IKKγ, which 
leads to the induction of NF‑κB (right side).
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